Suspected cancer: recognition and referral (NG12)
This NICE guidance outlines recommendations for children and adults with suspected cancer, including primary care investigations and referral recommendations to secondary care.
Lenalidomide maintenance treatment demonstrates significant overall survival benefit following HDT-ASCT
Meta-analysis of results from three randomised control trials has demonstrated that maintenance treatment with lenalidomide (Revlimid®) following high-dose therapy and autologous stem cell transplantation (HDT-ASCT) in newly diagnosed myeloma patients has a significant overall survival (OS) benefit. Published in the Journal of Clinical Oncology, the results of this meta-analysis, which used data pooled from the…
Guidelines for the use of imaging in the management of patients with myeloma
These updated guidelines, produced by the British Society of Haematology and Myeloma UK summarise a national consensus for the use of imaging in the diagnosis and management of myeloma patients.